Efficient Epidermal Growth Factor Receptor Targeting Oligonucleotide as a Potential Molecule for Targeted Cancer Therapy
出版年份 2019 全文链接
标题
Efficient Epidermal Growth Factor Receptor Targeting Oligonucleotide as a Potential Molecule for Targeted Cancer Therapy
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 19, Pages 4700
出版商
MDPI AG
发表日期
2019-09-23
DOI
10.3390/ijms20194700
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A Detailed Protein-SELEX Protocol Allowing Visual Assessments of Individual Steps for a High Success Rate
- (2019) Tao Wang et al. Human Gene Therapy Methods
- Development of a nanoamorphous exosomal delivery system as an effective biological platform for improved encapsulation of hydrophobic drugs
- (2019) Phuong H.L. Tran et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development of Novel antimiRzymes for Targeted Inhibition of miR-21 Expression in Solid Cancer Cells
- (2019) Leon M. Larcher et al. MOLECULES
- Development of DNA aptamers targeting low-molecular-weight amyloid-β peptide aggregates in vitro
- (2018) Madhuri Chakravarthy et al. CHEMICAL COMMUNICATIONS
- Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
- (2018) Janick Selves et al. Cancers
- Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies
- (2018) Vincenzo di Noia et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development
- (2018) Tao Wang et al. BIOTECHNOLOGY ADVANCES
- Systematic Screening of Commonly Used Commercial Transfection Reagents towards Efficient Transfection of Single-Stranded Oligonucleotides
- (2018) Tao Wang et al. MOLECULES
- Fluorogenic RNA Aptamers: A Nano-platform for Fabrication of Simple and Combinatorial Logic Gates
- (2018) Victoria Goldsworthy et al. Nanomaterials
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties
- (2017) Quintin Hughes et al. MOLECULES
- Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression
- (2017) Fengmei Pi et al. Nature Nanotechnology
- Functionally-interdependent shape-switching nanoparticles with controllable properties
- (2017) Justin R. Halman et al. NUCLEIC ACIDS RESEARCH
- Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
- (2017) Simona Camorani et al. Scientific Reports
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
- (2017) Dongxi Xiang et al. Theranostics
- Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
- (2017) Hadi AlShamaileh et al. Scientific Reports
- In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies
- (2016) Farhana Lipi et al. RNA Biology
- RMBase: a resource for decoding the landscape of RNA modifications from high-throughput sequencing data
- (2015) Wen-Ju Sun et al. NUCLEIC ACIDS RESEARCH
- EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
- (2015) Tao Wang et al. Theranostics
- Evaluation of 2’-Deoxy-2’-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
- (2015) Silvana M G Jirka et al. Molecular Therapy-Nucleic Acids
- RNA aptamers targeting cancer stem cell marker CD133
- (2012) Sarah Shigdar et al. CANCER LETTERS
- Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer
- (2012) Meng Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ViennaRNA Package 2.0
- (2011) Ronny Lorenz et al. Algorithms for Molecular Biology
- A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
- (2011) Carla Lucia Esposito et al. PLoS One
- Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
- (2010) Markus Münz et al. Cancer Cell International
- An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
- (2009) M. Schmidt et al. ANNALS OF ONCOLOGY
- Amphiregulin: Role in Mammary Gland Development and Breast Cancer
- (2008) Jean McBryan et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started